Oncogene Addiction
NCI Center for Cancer Research Eminent Lecture
Dr. Felsher obtained a B.A. in Chemistry at the University of Chicago, a M.D. Ph.D. from the University of California, Los Angeles School of Medicine. He performed his graduate work in Molecular Biology/Immunology under Dr. Jonathan Braun. He trained in Internal Medicine at the Hospital of the University of Pennsylvania and Oncology at the University of California, San Francisco and his post-doctoral research under Dr. J. Michael Bishop. Dr. Felsher has been faculty at Stanford University for 16 years and performing both basic and translational cancer research and is the founding director of the Stanford TRAM Program.
Dr. Felsher has over 20 years of research experience working with experimental mouse models and has pioneered the utilization off the Tetracycline Regulatory System (Tet System) to generate conditional transgenic models of lymphoma, leukemia, osteosarcoma, hepatocellular carcinoma lung adenocarcinoma and renal cell carcinoma. He has demonstrated “reversibility of cancer,” “oncogene addiction,” and “tumor maintenance” through programs of cellular senescence and angiogenesis and differentiation. He has most recently described a critical role for the immune system in the mechanism of tumor regression upon oncogene inactivation.
Air date: 5/23/2016 3:00:00 PM
Source: Videocast - All Events - Category: Journals (General) Tags: Upcoming Events Source Type: video
More News: Addiction | Adenocarcinoma | Allergy & Immunology | Biology | Bone Cancers | Cancer | Cancer & Oncology | Carcinoma | Chemistry | General Medicine | Graduation | Hepatocellular Carcinoma | Hospitals | Internal Medicine | Kidney Cancer | Leukemia | Liver Cancer | Lymphoma | Molecular Biology | Osteosarcoma | Renal Cell Carcinoma | Tetracycline | University of Pennsylvania